114 related articles for article (PubMed ID: 11893865)
1. Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats.
Palmatier MI; Bevins RA
Neuropsychobiology; 2002; 45(2):87-94. PubMed ID: 11893865
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression.
Bevins RA; Besheer J; Pickett KS
Pharmacol Biochem Behav; 2001 Jan; 68(1):135-45. PubMed ID: 11274718
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
Mattingly BA; Himmler C; Bonta T; Rice LL
Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
[TBL] [Abstract][Full Text] [Related]
4. Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
Guy EG; Fletcher PJ
Pharmacol Biochem Behav; 2014 Oct; 125():40-47. PubMed ID: 25158104
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Sheppard B; Lehmann J; Cope ZA; Brown RW
Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
[TBL] [Abstract][Full Text] [Related]
6. The incentive amplifying effects of nicotine are reduced by selective and non-selective dopamine antagonists in rats.
Palmatier MI; Kellicut MR; Brianna Sheppard A; Brown RW; Robinson DL
Pharmacol Biochem Behav; 2014 Nov; 126():50-62. PubMed ID: 25230311
[TBL] [Abstract][Full Text] [Related]
7. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats.
O'Neill MF; Dourish CT; Iversen SD
Psychopharmacology (Berl); 1991; 104(3):343-50. PubMed ID: 1833784
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of dopamine receptors in conditioned suppression induced by cocaine.
Grakalic I; Panlilio LV; Thorndike EB; Schindler CW
Eur J Pharmacol; 2007 Nov; 573(1-3):116-23. PubMed ID: 17628537
[TBL] [Abstract][Full Text] [Related]
10. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
Harrison AA; Gasparini F; Markou A
Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization.
White FJ; Joshi A; Koeltzow TE; Hu XT
Neuropsychopharmacology; 1998 Jan; 18(1):26-40. PubMed ID: 9408916
[TBL] [Abstract][Full Text] [Related]
12. Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.
Bubar MJ; Pack KM; Frankel PS; Cunningham KA
Psychopharmacology (Berl); 2004 May; 173(3-4):326-36. PubMed ID: 15064911
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.
Jeziorski M; White FJ
Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290
[TBL] [Abstract][Full Text] [Related]
14. Vendor differences in alcohol consumption and the contribution of dopamine receptors to Pavlovian-conditioned alcohol-seeking in Long-Evans rats.
Sparks LM; Sciascia JM; Ayorech Z; Chaudhri N
Psychopharmacology (Berl); 2014 Feb; 231(4):753-64. PubMed ID: 24096535
[TBL] [Abstract][Full Text] [Related]
15. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
Dias FR; Carey RJ; Carrera MP
Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
[TBL] [Abstract][Full Text] [Related]
16. Effects of dopamine receptor antagonism and amphetamine-induced psychomotor sensitization on sign- and goal-tracking after extended training.
Khoo SY; Uhrig A; Samaha AN; Chaudhri N
Behav Brain Res; 2021 Jun; 407():113238. PubMed ID: 33744334
[TBL] [Abstract][Full Text] [Related]
17. Novel-object place conditioning: behavioral and dopaminergic processes in expression of novelty reward.
Bevins RA; Besheer J; Palmatier MI; Jensen HC; Pickett KS; Eurek S
Behav Brain Res; 2002 Feb; 129(1-2):41-50. PubMed ID: 11809493
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
Hoque KE; West AR
Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus.
Murray JE; Bevins RA
Eur J Pharmacol; 2007 Apr; 561(1-3):91-104. PubMed ID: 17343849
[TBL] [Abstract][Full Text] [Related]
20. Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats.
Besheer J; Jensen HC; Bevins RA
Behav Brain Res; 1999 Aug; 103(1):35-44. PubMed ID: 10475162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
